SCHEMBL30952974

SCHEMBL30952974

CC(C)(C)OC(=O)N[C@H](C(=O)Nc1cc(CN2C[C@@H](C(F)(F)F)NC2=O)ccn1)C1CCC(F)(F)CC1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ IL17A Q16552 6/20 0.42
▸ IGF1R P08069 1/20 0.38
▸ AAK1 Q2M2I8 4/20 0.37
▸ ABCB11 O95342 1/20 0.33
▸ CHRM2 P08172 1/20 0.33
▸ SLCO1B1 Q9Y6L6 1/20 0.33
▸ MMP1 P03956 1/20 0.33
▸ SCN9A Q15858 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ MAPK14 Q16539 1/20 0.31
▸ CDK5 Q00535 1/20 0.31
▸ DYRK1A Q13627 1/20 0.31
▸ CDK5R1 Q15078 1/20 0.31
▸ PSEN1 P49768 1/20 0.31
▸ PSEN2 P49810 1/20 0.31
▸ APH1B Q8WW43 1/20 0.31
▸ NCSTN Q92542 1/20 0.31
▸ APH1A Q96BI3 1/20 0.31
▸ PSENEN Q9NZ42 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30952956 0.91 AAK1 (0.40) IL17AIGF1RAAK1MMP1SCN9A
SCHEMBL30953159 0.88 IL17A (0.40) IL17AMAPK1
SCHEMBL30953080 0.86 IL17A (0.41) IL17AABCB11CHRM2SLCO1B1MAPK1
SCHEMBL30952938 0.85 IL17A (0.45) IL17AABCB11CHRM2SLCO1B1
SCHEMBL30952986 0.85 IGF1R (0.39) IL17AIGF1RAAK1SCN9ACDK5
SCHEMBL30953257 0.85 IL17A (0.40) IL17AMAPK1
SCHEMBL30953460 0.85 AAK1 (0.37) IL17AAAK1ABCB11CHRM2SLCO1B1
Hydrochloric Acid SCHEMBL30953455 0.84 IL17A (0.43) IL17AIGF1RABCB11CHRM2SLCO1B1
SCHEMBL30953439 0.83 AAK1 (0.44) IGF1RAAK1MMP1MAPK1MAPK14
SCHEMBL30953210 0.83 AAK1 (0.46) IGF1RAAK1MMP1MAPK1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP claimed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO claimed
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback